Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma

por Sachpekidis, Christos, Goldschmidt, Hartmut, Dimitrakopoulou-Strauss, Antonia
Publicado 2019

Navigating the treatment landscape in multiple myeloma: which combinations to use and when?

por Goldschmidt, Hartmut, Ashcroft, John, Szabo, Zsolt, Garderet, Laurent
Publicado 2018

Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in...

por Sachpekidis, Christos, Dimitrakopoulou-Strauss, Antonia, Delorme, Stefan, Goldschmidt, Hartmut
Publicado 2017

Imaging Features of Multiple Myeloma Extramedullary Lesions in the Liver with 18F-FDG PET/CT, Contrast-Enhanced CT and MRI

por Papamichail, Dimitris, Hog, Robert, Goldschmidt, Hartmut, Dimitrakopoulou-Strauss, Antonia
Publicado 2019

Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data

por Weisel, Katja, Ludwig, Heinz, Rieth, Achim, Lebioda, Andrea, Goldschmidt, Hartmut
Publicado 2019

Novel immunotherapies in multiple myeloma – chances and challenges

por Rasche, Leo, Wäsch, Ralph, Munder, Markus, Goldschmidt, Hartmut, Raab, Marc S.
Publicado 2021

Diagnostic and therapeutic approaches to multiple myeloma patients: ‘Real-world’ data from representative multicentre treatment surveys in Germany between 2008 and 2011

por Moehler, Thomas M., Merz, Maximilian, Kellermann, Lenka, Goldschmidt, Hartmut, Knauf, Wolfgang
Publicado 2016

Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology—Highlights of the 8th Heidelberg Myeloma Workshop

por Lutz, Raphael, Friedrich, Mirco, Raab, Marc Steffen, Weinhold, Niels, Goldschmidt, Hartmut
Publicado 2021

Physical activity-related health competence and symptom burden for exercise prescription in patients with multiple myeloma: a latent profile analysis

por Kuehl, Rea, Koeppel, Maximilian, Goldschmidt, Hartmut, Maatouk, Imad, Rosenberger, Friederike, Wiskemann, Joachim
Publicado 2023

Chetomin, targeting HIF-1α/p300 complex, exhibits antitumour activity in multiple myeloma

por Viziteu, Elena, Grandmougin, Camille, Goldschmidt, Hartmut, Seckinger, Anja, Hose, Dirk, Klein, Bernard, Moreaux, Jerome
Publicado 2016

The Incidence of Senile Cataract and Glaucoma is Increased in Patients with Plasma Cell Dyscrasias: Etiologic Implications

por Hemminki, Kari, Försti, Asta, Tuuminen, Raimo, Hemminki, Otto, Goldschmidt, Hartmut, Sundquist, Kristina, Sundquist, Jan, Li, Xinjun
Publicado 2016

Germline Risk Contribution to Genomic Instability in Multiple Myeloma

por Janz, Siegfried, Zhan, Fenghuang, Sun, Fumou, Cheng, Yan, Pisano, Michael, Yang, Ye, Goldschmidt, Hartmut, Hari, Parameswaran
Publicado 2019

Identification of Pluripotent and Adult Stem Cell Genes Unrelated to Cell Cycle and Associated with Poor Prognosis in Multiple Myeloma

por Kassambara, Alboukadel, Hose, Dirk, Moreaux, Jérôme, Rème, Thierry, Torrent, Jennifer, Rossi, Jean François, Goldschmidt, Hartmut, Klein, Bernard
Publicado 2012

Inhibition of DEPDC1A, a Bad Prognostic Marker in Multiple Myeloma, Delays Growth and Induces Mature Plasma Cell Markers in Malignant Plasma Cells

por Kassambara, Alboukadel, Schoenhals, Matthieu, Moreaux, Jérôme, Veyrune, Jean-Luc, Rème, Thierry, Goldschmidt, Hartmut, Hose, Dirk, Klein, Bernard
Publicado 2013

Cell-based immunotherapy approaches for multiple myeloma

por Kriegsmann, Katharina, Kriegsmann, Mark, Cremer, Martin, Schmitt, Michael, Dreger, Peter, Goldschmidt, Hartmut, Müller-Tidow, Carsten, Hundemer, Michael
Publicado 2018

Can (18)F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?

por Sachpekidis, Christos, Kopp-Schneider, Annette, Merz, Maximilian, Jauch, Anna, Raab, Marc-Steffen, Goldschmidt, Hartmut, Dimitrakopoulou-Strauss, Antonia
Publicado 2020

A new method for class prediction based on signed-rank algorithms applied to Affymetrix(® )microarray experiments

por Rème, Thierry, Hose, Dirk, De Vos, John, Vassal, Aurélien, Poulain, Pierre-Olivier, Pantesco, Véronique, Goldschmidt, Hartmut, Klein, Bernard
Publicado 2008

Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myeloma

por Maatouk, Imad, He, Susanne, Hummel, Manuela, Hemmer, Stefan, Hillengass, Michaela, Goldschmidt, Hartmut, Hartmann, Mechthild, Herzog, Wolfgang, Hillengass, Jens
Publicado 2019

Prognostic significance of tumor burden assessed by whole-body magnetic resonance imaging in multiple myeloma patients treated with allogeneic stem cell transplantation

por Mosebach, Jennifer, Shah, Sofia, Delorme, Stefan, Hielscher, Thomas, Goldschmidt, Hartmut, Schlemmer, Heinz-Peter, Schönland, Stefan, Hegenbart, Ute, Hillengass, Jens
Publicado 2018

Flow cytometry‐based characterization of underlying clonal B and plasma cells in patients with light chain amyloidosis

por Lisenko, Katharina, Schönland, Stefan O., Jauch, Anna, Andrulis, Mindaugas, Röcken, Christoph, Ho, Anthony D., Goldschmidt, Hartmut, Hegenbart, Ute, Hundemer, Michael
Publicado 2016